CPB2 p.Arg342Cys
c.1024C>T · VCV4656031
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1551 | likely benign |
|---|---|---|
| REVEL | 0.101 | moderately benign-leaning |
| SaProt | LLR -11.32 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.3 | GERP 0.88, phastCons 1 |
| Regional constraint | o/e 0.83 | unconstrained · MANE · 51 kb · p 0.00014 · regional, not allelic |
| Overall | ||
| CADD | 24.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0045% | 22,217 |
| Remaining individualsnot grpmax-eligible | 0.00323% | 30,975 |
| African / African-American | 0.00134% | 74,430 |
| European (non-Finnish) | 0.00103% | 97,560 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CPB2
- Protein
- p.Arg342Cys
- Coding
- c.1024C>T
- MANE Select
- NM_001872
- Type
- single nucleotide variant
- Location
- chr13:46055825 (GRCh38)
- Gene constraint
- LOEUF 1.373 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.32 · 10 PDB
- Residue 342
- the peptidase m14 domain; an α-helix
Similar variants
- CPB2 p.Asp142= Benign ★★ same type
- CPB2 p.Tyr245= Likely benign ★★ same type
- CPB2 p.Ala22Thr Uncertain significance ★ ⚠ same type
- CPB2 p.Ala246Val Uncertain significance ★ ⚠ same type
- CPB2 p.Ala340Thr Uncertain significance ★ ⚠ same type
- CPB2 p.Ala411Thr Uncertain significance ★ ⚠ same type
- CPB2 p.Ala74Thr Uncertain significance ★ ⚠ same type
- CPB2 p.Ala7Glu Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpb2-p-arg342cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown